Covered recipient · General Payments record
KRISHMA ZAVER
Eye and Vision Services Providers Optometrist
General Payments · PY2021–2024
$3,414.64
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $858.10 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $204.19 | 7 |
| Harrow Eye, LLC | $178.09 | 3 |
| Dompe US, Inc. | $124.97 | 1 |
| CooperVision Inc. | $106.91 | 1 |
| Tarsus Pharmaceuticals, Inc. | $95.79 | 1 |
| Johnson & Johnson Surgical Vision, Inc. | $60.79 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.27 | 1 |
| Alcon Laboratories Inc | $36.08 | 1 |
| Bausch & Lomb Americas Inc. | $15.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.21 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391660 | CMS |
| ABBVIE INC. | $25.18 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391662 | CMS |
| ABBVIE INC. | $31.33 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391664 | CMS |
| ABBVIE INC. | $34.66 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391666 | CMS |
| ABBVIE INC. | $29.39 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391668 | CMS |
| ABBVIE INC. | $31.69 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391670 | CMS |
| ABBVIE INC. | $33.73 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106391672 | CMS |
| Alcon Vision LLC | $36.08 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110722622 | CMS |
| Bausch & Lomb Americas Inc. | $15.01 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140389592 | CMS |
| CooperVision Inc. | $106.91 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145473610 | CMS |
| Dompe US, Inc. | $124.97 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151408757 | CMS |
| Harrow Eye, LLC | $25.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145623521 | CMS |
| Harrow Eye, LLC | $120.55 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145623525 | CMS |
| Harrow Eye, LLC | $31.57 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145623529 | CMS |
| Johnson & Johnson Surgical Vision, Inc. | $60.79 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077596152 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.27 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152170706 | CMS |
| Tarsus Pharmaceuticals, Inc. | $95.79 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139143576 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.